BiotechTube
Home/BreStem Therapeutics/Ke Cheng, Ph.D.
KC

Ke Cheng, Ph.D.

Founder

BreStem Therapeutics

Therapeutic Areas

Pulmonary FibrosisDegenerative Lung Diseases

BreStem Therapeutics Pipeline

DrugIndicationPhase
BRS101Idiopathic Pulmonary FibrosisPhase 1
BRS201Pulmonary Fibrosis (implied)Pre-IND